Cryovials Market

The global cryovials market is projected to reach USD 0.31 billion by 2031, up from USD 0.24 billion in 2026, reflecting a 5.5% CAGR from 2026 to 2031. The healthcare cryovials market is experiencing significant growth, driven by the expanding adoption of hospital-based biobanking and cord blood and stem cell storage programs. The rising volume of clinical diagnostics, molecular testing, and biological sample collection is further driving demand for reliable cryogenic storage solutions that preserve sample integrity over extended periods.

In addition, the rapid scale-up of cell and gene therapy development and manufacturing is increasing demand for high-quality cryovials to store and transport sensitive biological materials. Growing regulatory emphasis on cold-chain integrity, sample traceability, and standardized storage practices across healthcare institutions is also supporting market growth, encouraging healthcare providers and laboratories to adopt advanced cryovial solutions with improved durability, identification, and tracking capabilities.

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific Inc. (US)

Thermo Fisher Scientific is a leading provider of cryovials and cryogenic storage consumables, delivering comprehensive sample-preservation solutions through its Thermo Scientific and Nunc brands. These solutions span internally and externally threaded, self-standing, and barcoded cryovial formats. The company's cryovial portfolio is engineered to withstand ultra-low temperatures down to -196°C, supporting long-term storage of cells, tissues, and biological fluids in hospital biobanks, clinical diagnostic laboratories, and cell and gene therapy manufacturing facilities. Thermo Fisher serves academic research institutions, pharmaceutical and biotechnology companies, and clinical laboratories worldwide. It invests heavily in R&D to integrate low-binding polymer formulations, robust sealing technologies, and 2D-barcoded tracking systems into its cryovials, enhancing sample integrity and traceability for complex healthcare workflows. Its strong focus on innovation and regulatory-compliant manufacturing positions it as a key enabler of hospital biobanking and precision medicine programs. The company operates in more than 50 countries across North America, Europe, APAC, and Latin America. It has adopted inorganic growth strategies, such as acquisitions, to strengthen its position in the cryogenic storage consumables market.

Corning Incorporated  (US)

Corning Incorporated is a global leader in cryovials and cryogenic labware, offering a diverse portfolio of self-standing and round-bottom cryogenic vials under its Corning brand, widely used across biotechnology, pharmaceutical, and hospital-based clinical research settings. Corning's cryovials are engineered with silicone O-ring seals and externally threaded closures to prevent leakage and cross-contamination during long-term ultra-low-temperature and vapor-phase liquid nitrogen storage, a critical requirement for hospital biobanks, cord blood banks, and reproductive tissue repositories. The company emphasizes manufacturing consistency and material traceability, supporting compliance with healthcare regulatory standards for sample documentation and chain of custody. As its cryovials are increasingly integrated into automated laboratory and cold-chain workflows, Corning continues to enhance sample security and operational efficiency for hospital diagnostic laboratories and biopharmaceutical manufacturers, making it a key enabler of cryopreservation practices in modern healthcare delivery worldwide.

Merck KGaA (Germany)

Merck KGaA, through its life science business and affiliated brands, along with DWK Life Sciences, is a leading provider of glass and plastic cryovials and cryogenic labware, serving the pharmaceutical, biotechnology, academic, and clinical research sectors. The companies' combined portfolio spans borosilicate glass cryovials prized for chemical inertness in sensitive biologic storage, as well as polypropylene-based cryovials suited to high-volume hospital and diagnostic laboratory workflows. These products are essential for biobanking, cell and gene therapy sample management, and biopharmaceutical quality control. Merck and DWK Life Sciences continue to expand manufacturing capacity and pursue strategic acquisitions of specialized glass and laboratory packaging manufacturers to strengthen their footprint in cold-chain and cryogenic storage consumables. With continued investment in sterile, GMP-compliant production, the companies focus on supporting hospital biobanks, fertility clinics, and precision medicine programs, enabling healthcare providers to ensure reliable long-term sample integrity from collection through clinical use.

Market Ranking

The global cryovials market is moderately fragmented, with leading players including Thermo Fisher Scientific Inc. (US), Corning Incorporated (US), Merck KGaA/DWK Life Sciences (Germany), Avantor, Inc. (US), and Eppendorf SE (Germany). These companies maintain strong positions through broad product portfolios, advanced manufacturing capabilities, and a focus on high-quality sample storage solutions.

A key growth driver for Thermo Fisher Scientific, Corning, and Merck KGaA/DWK Life Sciences is rising demand from hospitals and diagnostic laboratories for certified, sterile, and traceable cryovials to support expanding biobanking programs, cord blood and stem cell repositories, and cell and gene therapy sample management. Growing investments in precision oncology, liquid biopsy diagnostics, and regenerative medicine are further increasing demand for cryovials with low DNA/RNA binding, reliable sealing, high chemical resistance, and barcode-based traceability. Thermo Fisher Scientific benefits from its extensive range of cryogenic consumables and integrated sample-tracking solutions. Corning leverages its large-scale manufacturing capabilities and established expertise in leak-resistant sealing technologies, while Merck KGaA/DWK Life Sciences draws on its packaging expertise and GMP-compliant manufacturing capabilities for sensitive biological samples. These companies are supported by rising government and hospital investments in biobanking infrastructure, the growing adoption of personalized and regenerative medicine, and ongoing technological advancements aimed at improving sterility, sample traceability, and cold-chain compliance.

Other notable participants include SARSTEDT AG & Co. KG, Sumitomo Bakelite Co., Ltd., Biologix Group Limited, Brooks Automation, Inc., and Simport Scientific. These regional and specialized manufacturers compete on cost efficiency, production capacity, product customization, and specialized solutions tailored to hospital and clinical laboratory needs. Overall, competitive dynamics in the healthcare segment of the cryovials market are shaped by the growing need for validated, contamination-free, durable, and traceable sample-storage solutions across hospital biobanks, diagnostic laboratories, research institutions, and cell and gene therapy centers.

Related Reports:

Cryovials Market by Material (Polypropylene, Polyethylene, Glass), Application (Biobanking, Clinical Diagnostics, Cell & Gene Therapy, Drug Discovery), End User (Hospitals, Academia, Pharma-biopharma Cos., Biobanks) - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]